Re: Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted?

Samir S. Taneja

doi:10.1016/j.juro.2015.09.013

Re: Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted?

Samir S. Taneja

Biomedical Engineering

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	1631-1632
Number of pages	2
Journal	Journal of Urology
Volume	194
Issue number	6
DOIs	https://doi.org/10.1016/j.juro.2015.09.013
State	Published - Dec 2015

ASJC Scopus subject areas

Urology

Access to Document

10.1016/j.juro.2015.09.013

Cite this

@article{664038a48bac40049381a5bd4f582fe8,

title = "Re: Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted?",

author = "Taneja, {Samir S.}",

year = "2015",

month = dec,

doi = "10.1016/j.juro.2015.09.013",

language = "English (US)",

volume = "194",

pages = "1631--1632",

journal = "Journal of Urology",

issn = "0022-5347",

publisher = "Elsevier Inc.",

number = "6",

}

TY - JOUR

T1 - Re

T2 - Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted?

AU - Taneja, Samir S.

PY - 2015/12

Y1 - 2015/12

UR - http://www.scopus.com/inward/record.url?scp=84947280727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947280727&partnerID=8YFLogxK

U2 - 10.1016/j.juro.2015.09.013

DO - 10.1016/j.juro.2015.09.013

M3 - Comment/debate

C2 - 26582665

AN - SCOPUS:84947280727

SN - 0022-5347

VL - 194

SP - 1631

EP - 1632

JO - Journal of Urology

JF - Journal of Urology

IS - 6

ER -

Re: Adverse pathology and undetectable ultrasensitive prostate-specific antigen after radical prostatectomy: Is adjuvant radiation warranted?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this